AML Care Coordination in the Community Setting
Listen now
Description
Coordination of care for patients diagnosed with acute myeloid leukemia, particularly those who are ineligible for transplant, can impact access to specialist care, clinical trials, and cancer programs with advanced capabilities to treat patients with acute myeloid leukemia. In this episode, CANCER BUZZ speaks with Geoffrey Uy, MD, professor of Bone Marrow Transplantation and Leukemia at Washington University’s School of Medicine in St. Louis, Missouri and Khoan Tuong Vu, MD, hematologist oncologist at Texas Oncology, who share strategies and best practices for co-managing care for patients with acute myeloid leukemia.   “The impact of care coordination can be tremendous. A large proportion of our patients come from several hours away. Through care coordination and through things like telehealth, we can deliver high quality care to patients in their [own] community.” – Geoffrey L. Uy, MD “Successful care coordination is a seamless transition of care where we work together as a cohesive team, even across different cancer centers, with a consistent message and consistent treatment plan.” – Khoan Tuong Vu, MD   Guest:              Geoffrey L. Uy, MD Professor of Medicine, Bone Marrow Transplantation & Leukemia\ Division of Oncology Washington University School of Medicine St. Louis, MO   Khoan Tuong Vu, MD Hematologist Oncologist Texas Oncology Dallas, TX     This is the third episode of a four-part series developed in connection with the ACCC education program Achieving and Maintaining Better Outcomes for Patients with Acute Myeloid Leukemia. This episode was made possible with support by Bristol Myers-Squibb.   Additional Reading/Sources ·       Critical Conversation Strategies for Patients with AML- Video Podcast Ep 37 ·       Strategies to Addressing Disparities in Patients with AML – Video Podcast Ep 35 ·       Shared Decision-making in Acute Myeloid Leukemia ·       Talking about Acute Myeloid Leukemia (Cancer Support Community) ·       Shared Decision-making: Practical Implementation for the Oncology Team (ACCC)
More Episodes
The range of frontline therapy options for mantle cell lymphoma can influence subsequent treatment choices for patients with relapsed or refractory disease. Providers must determine initial treatment based on individual patient characteristics, while also factoring in future treatment options. In...
Published 09/19/24
Advancements in treatment combined with a multimodal approach are improving outcomes for patients with head and neck cancer. However, the unique challenges of a head and neck cancer diagnosis and its treatment side effects—such as speech and communication difficulties as well as negative effects...
Published 09/12/24
Published 09/12/24